Unedited news and product information from vendors.
VentureHealth Launches New Model for Funding Healthcare Innovations
May 17, 2013 (11:05 AM EDT)
SAN JOSE, Calif., May 17, 2013 /PRNewswire/ -- VentureHealth, an online healthcare investment portal for accredited investors, today announced a new model for equity crowdfunding. Focused on innovations that dramatically improve clinical outcomes, VentureHealth is the first equity crowdfunding portal founded by professional investors. The investment platform offers qualified investors access to life sciences deals that traditionally were reserved for venture capitalists.
VentureHealth is led by a seasoned team with extensive success in the healthcare industry. Mir Imran, Co-Founder and Managing Director, is a prolific medical innovator who has founded more than 20 life sciences companies and holds more than 200 patents. Mir is also the founder of InCube Labs, a multi-disciplinary research lab that develops breakthrough medical technologies, and InCube Ventures, a life sciences venture fund. Andrew Farquharson, Co-Founder and Managing Director of VentureHealth, is an investor and entrepreneur with two decades of experience building, restructuring and acquiring companies in life sciences. A Harvard MBA, Andrew is also a founding member of InCube Ventures and an advisor to InCube Labs. Talat Imran, the third Co-Founder and Managing Director, is an accomplished entrepreneur in the world of digital media.
"Venture capital for early stage life sciences companies has dried up in the last few years, and promising companies are always looking for investors. VentureHealth has the potential to change how healthcare innovations are funded, which is a win for both entrepreneurs and investors," said Mir Imran, Co-Founder and Managing Director.
"We founded VentureHealth so that physicians and other accredited investors can invest in the most compelling biomedical innovations," said Andrew Farquharson, Co-Founder and Managing Director. "This model gives individuals access to high-quality deals, investing on terms offered to professional VCs. It's a paradigm shift and, if we're successful, this could change the landscape for biomedical financing."
VentureHealth is also announcing today that it raised $875,000 as part of a Series B round for Channel Medsystems, a start-up developing next generation cryoablation technologies.
"We love this new approach," said Dan Burnett, Founder of Channel Medsystems. "VentureHealth is very attractive for companies like ours because it creates new financing options, and makes the whole funding ecosystem less VC dependent. That is a very big deal to entrepreneurs."
In launching the online portal, VentureHealth is able to expand the community of investors while offering a limited number of carefully selected investment opportunities at any given time.
Astro Teller, serial entrepreneur and scientist who oversees Google[x], Google's audacious ideas lab and "moonshot factory," is not affiliated with VentureHealth but sees the potential of the model. "Democratizing access to private markets is a powerful concept, and VentureHealth gets us a step closer to this vision. It's opening doors for individual investors, giving them access to deals they wouldn't be able to participate in otherwise. Even more interesting, it's giving these investors a forum to interact and engage with the community. There's no doubt that 100 qualified people evaluating a deal make a better decision than one individual investor."
Registered potential investors can log into www.venturehealth.com to see the most current offerings and to sign up to receive notifications when new investments become available. Those seeking life science investment opportunities must understand the risks associated with equity investments and are encouraged to consider investment diversification.